2023-2028年世界および地域のPCRおよびNGSベースの分子診断薬産業の現状と展望専門市場調査報告書標準版

2023-2028 Global and Regional PCR and NGS-Based Molecular Diagnostics Industry Status and Prospects Professional Market Research Report Standard Version

HNY Research社の最新レポートによると、世界のPCRおよびNGSベースの分子診断市場は、2023年から2028年にかけてXX%の年平均成長率で、2028年までにXX百万米ドルに達すると予測されている。本レポートの主な目的... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
HNY Research HNYリサーチ	2023年10月18日	US$3,500 シングルユーザライセンスライセンス・価格情報注文方法はこちら	168	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

HNY Research社の最新レポートによると、世界のPCRおよびNGSベースの分子診断市場は、2023年から2028年にかけてXX%の年平均成長率で、2028年までにXX百万米ドルに達すると予測されている。
本レポートの主な目的は、COVID-19後の影響に関する洞察を提供し、この分野の市場プレイヤーのビジネスアプローチの評価に役立てることです。また、主要市場、タイプ、用途/エンドユーザー、地域（北米、東アジア、ヨーロッパ、南アジア、東南アジア、中東、アフリカ、オセアニア、南米）による市場細分化もカバーしています。

市場ベンダー別
サーモフィッシャー
ピラーバイオサイエンス
ロシュ
イルミネーション
アジレント
パラゴンジェノミクス
アイジェン・テクノロジーズ
バイオサイエンティフィック
キアゲン
LCバイオテクノロジーズ（杭州）CO.LTD.
バーニングロック

タイプ別
バイオマーカー探索
血液サンプル検査
その他

アプリケーション別
病院
学術・研究機関
その他

主な分析指標
市場プレイヤーと競合分析：本レポートは、会社概要、製品仕様、生産能力/売上高、売上高、価格、売上総利益2017-2028 & 売上高を含む業界の主要プレイヤーを網羅し、市場の競争環境とベンダーの詳細情報、主要市場ベンダーの成長を妨げる要因の包括的な詳細を徹底分析します。
世界市場と地域市場の分析本レポートには、世界＆地域市場の現状と展望2017-2028が含まれています。さらに、本レポートでカバーしている各地域＆国についての詳細な内訳を提供しています。その売上高、販売量、収益予測を特定します。種類別、用途別の詳細な分析も掲載しています。
市場動向：競争の激化と継続的な技術革新を含む市場の主要動向。
機会と促進要因：高まる需要と新技術の特定。
ポーターズファイブフォース分析：新規参入の脅威、サプライヤーの交渉力、バイヤーの交渉力、代替製品やサービスの脅威、既存業界のライバルの脅威。

購入の主な理由
市場の洞察に満ちた分析を獲得し、世界市場とその商業状況を包括的に理解する。
生産プロセス、主要課題、開発リスクを軽減するための解決策を評価する。
市場で最も影響力のある推進力と抑制力、および世界市場への影響を理解する。
各主要組織が採用している市場戦略について知る。
市場の将来展望と見通しを理解する。
標準的な構成のレポートのほか、特定の要件に応じたカスタムリサーチも提供しています。

ページTOPに戻る

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global PCR and NGS-Based Molecular Diagnostics Market Size Analysis from 2023 to 2028
1.5.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global PCR and NGS-Based Molecular Diagnostics Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: PCR and NGS-Based Molecular Diagnostics Industry Impact
Chapter 2 Global PCR and NGS-Based Molecular Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global PCR and NGS-Based Molecular Diagnostics (Volume and Value) by Type
2.1.1 Global PCR and NGS-Based Molecular Diagnostics Consumption and Market Share by Type (2017-2022)
2.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue and Market Share by Type (2017-2022)
2.2 Global PCR and NGS-Based Molecular Diagnostics (Volume and Value) by Application
2.2.1 Global PCR and NGS-Based Molecular Diagnostics Consumption and Market Share by Application (2017-2022)
2.2.2 Global PCR and NGS-Based Molecular Diagnostics Revenue and Market Share by Application (2017-2022)
2.3 Global PCR and NGS-Based Molecular Diagnostics (Volume and Value) by Regions
2.3.1 Global PCR and NGS-Based Molecular Diagnostics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global PCR and NGS-Based Molecular Diagnostics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global PCR and NGS-Based Molecular Diagnostics Consumption by Regions (2017-2022)
4.2 North America PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
4.10 South America PCR and NGS-Based Molecular Diagnostics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America PCR and NGS-Based Molecular Diagnostics Market Analysis
5.1 North America PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
5.1.1 North America PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
5.2 North America PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
5.3 North America PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
5.4 North America PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
5.4.1 United States PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
5.4.2 Canada PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
5.4.3 Mexico PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 6 East Asia PCR and NGS-Based Molecular Diagnostics Market Analysis
6.1 East Asia PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
6.1.1 East Asia PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
6.2 East Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
6.3 East Asia PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
6.4 East Asia PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
6.4.1 China PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
6.4.2 Japan PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
6.4.3 South Korea PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 7 Europe PCR and NGS-Based Molecular Diagnostics Market Analysis
7.1 Europe PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
7.1.1 Europe PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
7.2 Europe PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
7.3 Europe PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
7.4 Europe PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
7.4.1 Germany PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.2 UK PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.3 France PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.4 Italy PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.5 Russia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.6 Spain PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.7 Netherlands PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.8 Switzerland PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
7.4.9 Poland PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 8 South Asia PCR and NGS-Based Molecular Diagnostics Market Analysis
8.1 South Asia PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
8.1.1 South Asia PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
8.2 South Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
8.3 South Asia PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
8.4 South Asia PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
8.4.1 India PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
8.4.2 Pakistan PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Analysis
9.1 Southeast Asia PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
9.1.1 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
9.2 Southeast Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
9.3 Southeast Asia PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
9.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
9.4.1 Indonesia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.2 Thailand PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.3 Singapore PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.4 Malaysia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.5 Philippines PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.6 Vietnam PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
9.4.7 Myanmar PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 10 Middle East PCR and NGS-Based Molecular Diagnostics Market Analysis
10.1 Middle East PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
10.1.1 Middle East PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
10.2 Middle East PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
10.3 Middle East PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
10.4 Middle East PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
10.4.1 Turkey PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.3 Iran PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.5 Israel PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.6 Iraq PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.7 Qatar PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.8 Kuwait PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
10.4.9 Oman PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 11 Africa PCR and NGS-Based Molecular Diagnostics Market Analysis
11.1 Africa PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
11.1.1 Africa PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
11.2 Africa PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
11.3 Africa PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
11.4 Africa PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
11.4.1 Nigeria PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.2 South Africa PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.3 Egypt PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.4 Algeria PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
11.4.5 Morocco PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 12 Oceania PCR and NGS-Based Molecular Diagnostics Market Analysis
12.1 Oceania PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
12.2 Oceania PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
12.3 Oceania PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
12.4 Oceania PCR and NGS-Based Molecular Diagnostics Consumption by Top Countries
12.4.1 Australia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
12.4.2 New Zealand PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 13 South America PCR and NGS-Based Molecular Diagnostics Market Analysis
13.1 South America PCR and NGS-Based Molecular Diagnostics Consumption and Value Analysis
13.1.1 South America PCR and NGS-Based Molecular Diagnostics Market Under COVID-19
13.2 South America PCR and NGS-Based Molecular Diagnostics Consumption Volume by Types
13.3 South America PCR and NGS-Based Molecular Diagnostics Consumption Structure by Application
13.4 South America PCR and NGS-Based Molecular Diagnostics Consumption Volume by Major Countries
13.4.1 Brazil PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.2 Argentina PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.3 Columbia PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.4 Chile PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.5 Venezuela PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.6 Peru PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
13.4.8 Ecuador PCR and NGS-Based Molecular Diagnostics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in PCR and NGS-Based Molecular Diagnostics Business
14.1 Thermofisher
14.1.1 Thermofisher Company Profile
14.1.2 Thermofisher PCR and NGS-Based Molecular Diagnostics Product Specification
14.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Pillar Biosciences
14.2.1 Pillar Biosciences Company Profile
14.2.2 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Specification
14.2.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Roche
14.3.1 Roche Company Profile
14.3.2 Roche PCR and NGS-Based Molecular Diagnostics Product Specification
14.3.3 Roche PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Illumine
14.4.1 Illumine Company Profile
14.4.2 Illumine PCR and NGS-Based Molecular Diagnostics Product Specification
14.4.3 Illumine PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Agilent
14.5.1 Agilent Company Profile
14.5.2 Agilent PCR and NGS-Based Molecular Diagnostics Product Specification
14.5.3 Agilent PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Paragon Genomics
14.6.1 Paragon Genomics Company Profile
14.6.2 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Specification
14.6.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 iGen Technologies
14.7.1 iGen Technologies Company Profile
14.7.2 iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Specification
14.7.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Bioo Scientific
14.8.1 Bioo Scientific Company Profile
14.8.2 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Specification
14.8.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Qiagen
14.9.1 Qiagen Company Profile
14.9.2 Qiagen PCR and NGS-Based Molecular Diagnostics Product Specification
14.9.3 Qiagen PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 LC-Bio Technologies (Hangzhou) CO. LTD.
14.10.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Profile
14.10.2 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Specification
14.10.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Burning Rock
14.11.1 Burning Rock Company Profile
14.11.2 Burning Rock PCR and NGS-Based Molecular Diagnostics Product Specification
14.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global PCR and NGS-Based Molecular Diagnostics Market Forecast (2023-2028)
15.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global PCR and NGS-Based Molecular Diagnostics Value and Growth Rate Forecast (2023-2028)
15.2 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global PCR and NGS-Based Molecular Diagnostics Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global PCR and NGS-Based Molecular Diagnostics Consumption Forecast by Type (2023-2028)
15.3.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Forecast by Type (2023-2028)
15.3.3 Global PCR and NGS-Based Molecular Diagnostics Price Forecast by Type (2023-2028)
15.4 Global PCR and NGS-Based Molecular Diagnostics Consumption Volume Forecast by Application (2023-2028)
15.5 PCR and NGS-Based Molecular Diagnostics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

ページTOPに戻る

Table of Contents

Summary

The global PCR and NGS-Based Molecular Diagnostics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Thermofisher
Pillar Biosciences
Roche
Illumine
Agilent
Paragon Genomics
iGen Technologies
Bioo Scientific
Qiagen
LC-Bio Technologies (Hangzhou) CO. LTD.
Burning Rock

By Types:
Biomarker Discovery
Blood Sample Testig
Others

By Applications:
Hospitals
Academics/Research Institutions
Others

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

HNY Research社のPharma & Healthcare分野での最新刊レポート

本レポートと同じKEY WORD（pcr）の最新刊レポート

2023-2028年世界および地域のリアルタイムPCR（RT-PCR）蛍光プローブ産業の現状と展望専門市場調査報告書標準版

よくあるご質問

HNY Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

2023-2028年世界および地域のPCRおよびNGSベースの分子診断薬産業の現状と展望専門市場調査報告書標準版

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

HNY Research社のPharma & Healthcare分野での最新刊レポート

本レポートと同じKEY WORD（pcr）の最新刊レポート

よくあるご質問

HNY Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?